Prostate Cancer Screening: PSA Test
A simple blood test measuring Prostate Specific Antigen (PSA), used as a screening tool for prostate enlargement, inflammation, or cancer. Recommended for men, particularly over 50 or with a family history of prostate cancer.
Bladder Cancer Screening: Urinary Bladder Cancer Antigen Test (UBC)
A non-invasive urine test that detects bladder cancer-specific antigens, especially useful for individuals with urinary symptoms or higher risk profiles (e.g., smokers).
Cervical Cancer Screening: Pap Smear & HPV DNA Test
- Pap Smear: Screens for abnormal cervical cells that may develop into cancer.
- HPV DNA Test: Detects high-risk strains of Human Papillomavirus associated with cervical and other cancers.
Bowel Cancer Screening: FIT (Faecal Immunochemical Test)
A stool test that checks for hidden (occult) blood, an early indicator of bowel cancer. Recommended for individuals aged 50+ or those with bowel symptoms.
Ovarian Cancer Screening: CA125 Blood Test
A blood test measuring CA125, a protein that can be elevated in ovarian cancer. Often used for women with ongoing pelvic symptoms or family history concerns.
Pancreatic & Gastrointestinal Cancer Marker: CA19-9 Blood Test
CA19-9 can be elevated in pancreatic and certain gastrointestinal cancers. Used in conjunction with clinical assessment.
Liver Cancer Screening: AFP (Alpha-fetoprotein) Blood Test
AFP is a blood marker useful for monitoring liver cancer risk, particularly in individuals with chronic liver conditions such as hepatitis B or C.
General Cancer Marker: CEA (Carcinoembryonic Antigen) Blood Test
CEA is a tumour marker that may be raised in colorectal and other cancers. Often used alongside other investigations when clinically indicated.
